Given substantial clinical heterogeneity in patient outcomes reported (i.e. retention, relapse rates, comorbidity management, satisfaction, etc.) and variability in the drug treatments and dosages used in the models (e.g. methadone versus buprenorphine) within the included studies, formal meta-analyses were not performed.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}